Fri | Jul 24, 2026

UK restricts exports on some drugs to reduce shortages

Published:Friday | October 4, 2019 | 11:43 AM
In this Tuesday, September 17, 2019 file photo, an employee of Eurotunnel and his dog check trucks on their way to Britain during a day of test in case of no-deal Brexit, at the exit of the Channel tunnel in Calais, northern France. (Denis Charlet, Pool via AP, file)

LONDON (AP) — Britain’s government on Thursday restricted the export of 24 drugs as part of efforts to reduce shortages of some medicines, including hormone replacement therapy drugs, Hepatitis B vaccines and adrenaline pens.

The restrictions announced will prevent wholesalers from taking advantage of short supplies and currency fluctuations to profit from selling medicines meant for U.K. patients to other countries for a higher price.

Although not directly linked to Brexit, Britain’s impending departure from the European Union _ the decision is important because it sets a precedent on addressing supply questions as the country moves closer to its October 31 departure from the bloc.

“The new measures we’re introducing today will help us ensure patients get the medicines they need and the high-quality care they deserve,’’ said Health Secretary Matt Hancock.

“Helping the (National Health Service) is a priority for this government, and people should be fully reassured that we will always act to ensure that there is an adequate supply of the medicine you need.”

Dr Rick Greville of the Association of the British Pharmaceutical Industry said the decision is a precaution.

“It means that these stockpiles of medicines, which companies have built over previous months, are better protected and available for use only by the NHS patients for which they were intended,’’ he said.

But the European Association of Euro-Pharmaceutical Companies, which represents 120 companies that distribute drugs in Europe, said Britain had failed to be transparent about the criteria it used to make its decision.

We want to hear from you! Send us a message on WhatsApp at 1-876-499-0169, email us at editors@gleanerjm.com or onlinefeedback@gleanerjm.com.